Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
Total Valuation
Medtronic has a market cap or net worth of $109.38B. The enterprise value is $137.14B.
Market Cap$109.38B
Enterprise Value$137.14B
Share Statistics
Medtronic has 1.28B shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1.28B
Owened by Insiders0.07%
Owened by Instutions19.73%
Financial Efficiency
Medtronic’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 4.90%.
Return on Equity (ROE)7.32%
Return on Assets (ROA)4.09%
Return on Invested Capital (ROIC)4.90%
Return on Capital Employed (ROCE)6.50%
Revenue Per Employee$349,463.158
Profits Per Employee$44,842.105
Employee Count95,000
Asset Turnover0.36
Inventory Turnover2.15
Valuation Ratios
The current PE Ratio of Medtronic is 28.80. Medtronic’s PEG ratio is -13.58.
PE Ratio28.80
PS Ratio3.27
PB Ratio2.11
Price to Fair Value2.11
Price to FCF20.36
Price to Operating Cash Flow15.60
PEG Ratio-13.58
Income Statement
In the last 12 months, Medtronic had revenue of $33.20B and earned $4.26B in profits. Earnings per share was $3.30.
Revenue$33.20B
Gross Profit$20.88B
Operating Income$6.05B
Pretax Income$5.22B
Net Income$4.26B
EBITDA9.39B
Earnings Per Share (EPS)3.30
Cash Flow
In the last 12 months, operating cash flow was $7.29B and capital expenditures -$1.83B, giving a free cash flow of $5.47B billion.
Operating Cash Flow$7.29B
Free Cash Flow$5.47B
Free Cash Flow per Share$4.26
Dividends & Yields
Medtronic pays an annual dividend of $0.70, resulting in a dividend yield of 3.39%
Dividend Per Share$0.70
Dividend Yield3.39%
Payout Ratio52.36%
Free Cash Flow Yield4.91%
Earnings Yield3.47%
Stock Price Statistics
Beta0.56
52-Week Price Change6.49%
50-Day Moving Average89.39
200-Day Moving Average85.15
Relative Strength Index (RSI)44.69
Average Volume (3m)8.47M
Important Dates
Medtronic upcoming earnings date is May 21, 2025, Before Open.
Last Earnings DateFeb 18, 2025
Next Earnings DateMay 21, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
Medtronic as a current ratio of 2.03, with Debt / Equity ratio of 0.52
Current Ratio2.03
Quick Ratio1.55
Debt to Market Cap0.24
Net Debt to EBITDA3.02
Interest Coverage Ratio7.15
Taxes
In the past 12 months, Medtronic has paid $934.00M in taxes.
Income Tax$934.00M
Effective Tax Rate23.42%
Enterprise Valuation
Medtronic EV to EBITDA ratio is 15.93, with an EV/FCF ratio of 25.12.
EV to Sales4.04
EV to EBITDA15.93
EV to Free Cash Flow25.12
EV to Operating Cash Flow19.25
Balance Sheet
Medtronic has $7.92B in cash and marketable securities with $26.61B in debt, giving a net cash position of $18.68B billion.
Cash & Marketable Securities$7.92B
Total Debt$26.61B
Net Cash$18.68B
Net Cash Per Share$14.57
Tangible Book Value Per Share-$2.86
Margins
Gross margin is 65.34%, with operating margin of 15.89%, and net profit margin of 11.36%.
Gross Margin65.34%
Operating Margin15.89%
Pretax Margin14.95%
Net Profit Margin11.36%
EBITDA Margin25.35%
EBIT Margin17.17%
Analyst Forecast
The average price target for Medtronic is $96.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$96.00
Price Target Upside15.80%
Analyst ConsensusModerate Buy
Analyst Count19
Revenue Growth Forecast2.72%
EPS Growth Forecast4.48%